Institutional investors purchased a net $4.4 million shares of IRWD during the quarter ended December 2017. This may signal that the smart money is gaining interest in this company as the 113.48% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Other industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HENDERSON GLOBAL INVESTORS LTD. Bought 8.3 Million shares of Ironwood Pharmaceuticals ...
SARISSA CAPITAL MANAGEMENT LP Bought 1.7 Million shares of Ironwood Pharmaceuticals ...